A detailed history of Mechanics Bank Trust Department transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mechanics Bank Trust Department holds 60,879 shares of BMY stock, worth $3.58 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
60,879
Previous 64,844 6.11%
Holding current value
$3.58 Million
Previous $2.69 Million 17.01%
% of portfolio
0.42%
Previous 0.39%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$39.66 - $51.75 $157,251 - $205,188
-3,965 Reduced 6.11%
60,879 $3.15 Million
Q2 2024

Jul 12, 2024

SELL
$40.25 - $52.99 $196,701 - $258,962
-4,887 Reduced 7.01%
64,844 $2.69 Million
Q1 2024

Apr 12, 2024

SELL
$47.98 - $54.4 $78,783 - $89,324
-1,642 Reduced 2.3%
69,731 $3.78 Million
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $660,540 - $788,206
-13,625 Reduced 16.03%
71,373 $3.66 Million
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $101,539 - $113,536
-1,754 Reduced 2.02%
84,998 $4.93 Million
Q2 2023

Jul 10, 2023

BUY
$63.71 - $70.74 $26,184 - $29,074
411 Added 0.48%
86,752 $5.55 Million
Q1 2023

Apr 10, 2023

SELL
$65.71 - $74.53 $146,204 - $165,829
-2,225 Reduced 2.51%
86,341 $5.98 Million
Q4 2022

Jan 23, 2023

SELL
$68.48 - $81.09 $69,712 - $82,549
-1,018 Reduced 1.14%
88,566 $0
Q3 2022

Oct 18, 2022

SELL
$0.13 - $76.84 $130 - $77,070
-1,003 Reduced 1.11%
89,584 $6.37 Million
Q2 2022

Jul 13, 2022

SELL
$72.62 - $79.98 $64,777 - $71,342
-892 Reduced 0.98%
90,587 $6.98 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $57,483 - $68,928
-935 Reduced 1.01%
91,479 $6.68 Million
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $52,825 - $61,582
-985 Reduced 1.05%
92,414 $5.76 Million
Q3 2021

Oct 28, 2021

SELL
$59.17 - $69.31 $32,543 - $38,120
-550 Reduced 0.59%
93,399 $5.53 Million
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $322,365 - $351,055
-5,207 Reduced 5.25%
93,949 $6.28 Million
Q1 2021

Apr 30, 2021

SELL
$59.34 - $66.74 $532,457 - $598,858
-8,973 Reduced 8.3%
99,156 $6.26 Million
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $4.67 Million - $5.29 Million
80,849 Added 296.37%
108,129 $6.71 Million
Q4 2020

Jan 27, 2021

SELL
$57.74 - $65.43 $4.67 Million - $5.29 Million
-80,799 Reduced 74.76%
27,280 $6.71 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $12,347 - $13,682
-215 Reduced 0.2%
108,079 $6.52 Million
Q2 2020

Jul 24, 2020

SELL
$54.82 - $64.09 $67,593 - $79,022
-1,233 Reduced 1.13%
108,294 $6.37 Million
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $22,272 - $32,366
480 Added 0.44%
109,527 $6.11 Million
Q4 2019

Jan 23, 2020

BUY
$49.21 - $64.19 $18,453 - $24,071
375 Added 0.35%
109,047 $7 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $110,988 - $131,592
-2,595 Reduced 2.33%
108,672 $5.51 Million
Q2 2019

Jul 17, 2019

SELL
$44.62 - $49.34 $26,905 - $29,752
-603 Reduced 0.54%
111,267 $5.05 Million
Q1 2019

Apr 24, 2019

SELL
$45.12 - $53.8 $26,395 - $31,473
-585 Reduced 0.52%
111,870 $5.34 Million
Q4 2018

Jan 29, 2019

SELL
$48.76 - $63.23 $26,330 - $34,144
-540 Reduced 0.48%
112,455 $5.85 Million
Q3 2018

Oct 26, 2018

SELL
$55.19 - $62.25 $33,114 - $37,350
-600 Reduced 0.53%
112,995 $7.02 Million
Q2 2018

Jul 23, 2018

BUY
$50.53 - $62.98 $64,526 - $80,425
1,277 Added 1.14%
113,595 $6.29 Million
Q1 2018

Apr 23, 2018

SELL
$59.92 - $68.98 $277,309 - $319,239
-4,628 Reduced 3.96%
112,318 $7.11 Million
Q4 2017

Jan 29, 2018

BUY
$59.94 - $65.35 $13,186 - $14,376
220 Added 0.19%
116,946 $7.17 Million
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $6.45 Million - $7.44 Million
116,726
116,726 $7.44 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mechanics Bank Trust Department Portfolio

Follow Mechanics Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mechanics Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Mechanics Bank Trust Department with notifications on news.